237 related articles for article (PubMed ID: 33716296)
1. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
[TBL] [Abstract][Full Text] [Related]
2. miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma.
Chen H; Xiao Z; Yu R; Wang Y; Xu R; Zhu X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1434-1441. PubMed ID: 30031607
[TBL] [Abstract][Full Text] [Related]
3. MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21
Fujii R; Osaka E; Sato K; Tokuhashi Y
Cancer Genomics Proteomics; 2019; 16(1):71-79. PubMed ID: 30587501
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis.
Zhang Z; Wu X; Han Q; Huang Z
Anticancer Drugs; 2021 Jun; 32(6):602-613. PubMed ID: 33595944
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.
Zhang W; Ding ML; Zhang JN; Qiu JR; Shen YH; Ding XY; Deng LF; Zhang WB; Zhu J
Sci Rep; 2015 Apr; 5():9604. PubMed ID: 25853231
[TBL] [Abstract][Full Text] [Related]
7. PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
Naudin C; Hattabi A; Michelet F; Miri-Nezhad A; Benyoucef A; Pflumio F; Guillonneau F; Fichelson S; Vigon I; Dusanter-Fourt I; Lauret E
Blood; 2017 May; 129(18):2493-2506. PubMed ID: 28232582
[TBL] [Abstract][Full Text] [Related]
8. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
11. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
12. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway.
Tong Z; Shen Y; Yuan Q; Yu H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
[TBL] [Abstract][Full Text] [Related]
13. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M
Cell Prolif; 2007 Aug; 40(4):532-49. PubMed ID: 17635520
[TBL] [Abstract][Full Text] [Related]
14. Armadillo Repeat-Containing Protein 8 (ARMC8) Silencing Inhibits Proliferation and Invasion in Osteosarcoma Cells.
Jiang F; Shi Y; Lu H; Li G
Oncol Res; 2016; 24(5):381-389. PubMed ID: 27712595
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
16. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
17. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
[TBL] [Abstract][Full Text] [Related]
18. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
Wan D; Jiang C; Hua X; Wang T; Chai Y
Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
[TBL] [Abstract][Full Text] [Related]
20. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
